A Phase 1/2 Trail of Enzastaurin and Erlotinib in Patien

  • Dudek, Arkadiusz Z (PI)

Project: Research project

Project Details

Description

A Phase 1/2 Trail of Enzastaurin and Erlotinib in Patients with Advanced Solid Tumors and Non-Small Cell Lung Cancer (NSCLC) after Prior Chemotherapy
StatusFinished
Effective start/end date8/21/079/15/11

Funding

  • Eli Lilly and Company

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.